Literature DB >> 23595119

Development of a focus-reduction neutralizing test for detecting equine herpesvirus type-1-neutralizing antibodies.

Hiroshi Bannai1, Manabu Nemoto, Koji Tsujimura, Takashi Yamanaka, Takashi Kondo, Tomio Matsumura.   

Abstract

Virus-neutralizing (VN) testing is essential for evaluating virus-specific immunity in equine herpesvirus type-1 (EHV-1) infection. We developed a focus-reduction neutralization test (FRNT) for EHV-1 using 96-well plates for faster large-scale testing with sufficient sensitivity. We used an overlay medium containing Avicel (FMC Biopolymer), a microcrystalline cellulose with lower viscosity than the methylcellulose. The foci were visualized by immuno-staining with anti-EHV-1 gp14 monoclonal antibody. The FRNT successfully detected seroconversion in horses experimentally infected with EHV-1 (n = 3) and in those infected naturally (n = 16). The FRNT for EHV-1 was high-throughput and time saving. The FRNT can be used in large-scale seroepidemiological studies of EHV-1 and in evaluating vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595119     DOI: 10.1292/jvms.13-0043

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Successful control of winter pyrexias caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage.

Authors:  Hiroshi Bannai; Naomi Mae; Hirotaka Ode; Manabu Nemoto; Koji Tsujimura; Takashi Yamanaka; Takashi Kondo; Tomio Matsumura
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

2.  Equine Herpesvirus Type 4 (EHV-4) Outbreak in Germany: Virological, Serological, and Molecular Investigations.

Authors:  Selvaraj Pavulraj; Kathrin Eschke; Jana Theisen; Stephanie Westhoff; Gitta Reimers; Sandro Andreotti; Nikolaus Osterrieder; Walid Azab
Journal:  Pathogens       Date:  2021-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.